Celine J Rocca1, Alexander Kreymerman2, Sarah N Ur1, Katie E Frizzi3, Swati Naphade1, Athena Lau1, Tammy Tran2, Nigel A Calcutt3, Jeffrey L Goldberg4, Stephanie Cherqui1. 1. Department of Pediatrics Division of Genetics, University of California, San Diego, La Jolla, California, United States. 2. Shiley Eye Center, University of California, San Diego, California, United States. 3. Department of Pathology, University of California, San Diego, California, United States. 4. Shiley Eye Center, University of California, San Diego, California, United States 4Byers Eye Institute, Stanford University, Palo Alto, California, United States.
Abstract
PURPOSE: Cystinosis is caused by a deficiency in the lysosomal cystine transporter, cystinosin (CTNS gene), resulting in cystine crystal accumulation in tissues. In eyes, crystals accumulate in the cornea causing photophobia and eventually blindness. Hematopoietic stem progenitor cells (HSPCs) rescue the kidney in a mouse model of cystinosis. We investigated the potential for HSPC transplantation to treat corneal defects in cystinosis. METHODS: We isolated HSPCs from transgenic DsRed mice and systemically transplanted irradiated Ctns-/- mice. A year posttransplantation, we investigated the fate and function of HSPCs by in vivo confocal and fluorescence microscopy (IVCM), quantitative RT-PCR (RT-qPCR), mass spectrometry, histology, and by measuring the IOP. To determine the mechanism by which HSPCs may rescue disease cells, we transplanted Ctns-/- mice with Ctns-/- DsRed HSPCs virally transduced to express functional CTNS-eGFP fusion protein. RESULTS: We found that a single systemic transplantation of wild-type HSPCs prevented ocular pathology in the Ctns-/- mice. Engraftment-derived HSPCs were detected within the cornea, and also in the sclera, ciliary body, retina, choroid, and lens. Transplantation of HSPC led to substantial decreases in corneal cystine crystals, restoration of normal corneal thickness, and lowered IOP in mice with high levels of donor-derived cell engraftment. Finally, we found that HSPC-derived progeny differentiated into macrophages, which displayed tunneling nanotubes capable of transferring cystinosin-bearing lysosomes to diseased cells. CONCLUSIONS: To our knowledge, this is the first demonstration that HSPCs can rescue hereditary corneal defects, and supports a new potential therapeutic strategy for treating ocular pathologies.
PURPOSE:Cystinosis is caused by a deficiency in the lysosomal cystine transporter, cystinosin (CTNS gene), resulting in cystine crystal accumulation in tissues. In eyes, crystals accumulate in the cornea causing photophobia and eventually blindness. Hematopoietic stem progenitor cells (HSPCs) rescue the kidney in a mouse model of cystinosis. We investigated the potential for HSPC transplantation to treat corneal defects in cystinosis. METHODS: We isolated HSPCs from transgenic DsRed mice and systemically transplanted irradiated Ctns-/- mice. A year posttransplantation, we investigated the fate and function of HSPCs by in vivo confocal and fluorescence microscopy (IVCM), quantitative RT-PCR (RT-qPCR), mass spectrometry, histology, and by measuring the IOP. To determine the mechanism by which HSPCs may rescue disease cells, we transplanted Ctns-/- mice with Ctns-/- DsRed HSPCs virally transduced to express functional CTNS-eGFP fusion protein. RESULTS: We found that a single systemic transplantation of wild-type HSPCs prevented ocular pathology in the Ctns-/- mice. Engraftment-derived HSPCs were detected within the cornea, and also in the sclera, ciliary body, retina, choroid, and lens. Transplantation of HSPC led to substantial decreases in corneal cystine crystals, restoration of normal corneal thickness, and lowered IOP in mice with high levels of donor-derived cell engraftment. Finally, we found that HSPC-derived progeny differentiated into macrophages, which displayed tunneling nanotubes capable of transferring cystinosin-bearing lysosomes to diseased cells. CONCLUSIONS: To our knowledge, this is the first demonstration that HSPCs can rescue hereditary corneal defects, and supports a new potential therapeutic strategy for treating ocular pathologies.
Authors: Robert Kleta; Frederick Kaskel; Ranjan Dohil; Paul Goodyer; Lisa M Guay-Woodford; Erik Harms; Julie R Ingelfinger; Vera H Koch; Craig B Langman; Mary B Leonard; Roslyn B Mannon; Minnie Sarwal; Jerry A Schneider; Flemming Skovby; Barbara C Sonies; Jess G Thoene; Doris A Trauner; William A Gahl Journal: Pediatr Nephrol Date: 2005-01-27 Impact factor: 3.714
Authors: Ekaterini T Tsilou; Benjamin I Rubin; George F Reed; Fumino Iwata; William Gahl; Muriel I Kaiser-Kupfer Journal: Cornea Date: 2002-03 Impact factor: 2.651
Authors: Brian A Yeagy; Frank Harrison; Marie-Claire Gubler; James A Koziol; Daniel R Salomon; Stephanie Cherqui Journal: Kidney Int Date: 2011-01-19 Impact factor: 10.612
Authors: Debbie K Chen; Katie E Frizzi; Lucie S Guernsey; Kelsey Ladt; Andrew P Mizisin; Nigel A Calcutt Journal: J Peripher Nerv Syst Date: 2013-12 Impact factor: 3.494
Authors: Frank Harrison; Brian A Yeagy; Celine J Rocca; Donald B Kohn; Daniel R Salomon; Stephanie Cherqui Journal: Mol Ther Date: 2012-10-23 Impact factor: 11.454
Authors: Jennifer Simpson; Chyong Jy Nien; Kevin Flynn; Brian Jester; Stephanie Cherqui; James Jester Journal: Mol Vis Date: 2011-08-17 Impact factor: 2.367
Authors: Diana M Iglesias; Reyhan El-Kares; Anna Taranta; Francesco Bellomo; Francesco Emma; Martine Besouw; Elena Levtchenko; Jaan Toelen; Lambertus van den Heuvel; Leelee Chu; Jing Zhao; Yoon Kow Young; Nicoletta Eliopoulos; Paul Goodyer Journal: PLoS One Date: 2012-08-13 Impact factor: 3.240
Authors: Celine J Rocca; Spencer M Goodman; Jennifer N Dulin; Joseph H Haquang; Ilya Gertsman; Jordan Blondelle; Janell L M Smith; Charles J Heyser; Stephanie Cherqui Journal: Sci Transl Med Date: 2017-10-25 Impact factor: 17.956
Authors: H P Gaide Chevronnay; V Janssens; P Van Der Smissen; C J Rocca; X H Liao; S Refetoff; C E Pierreux; S Cherqui; P J Courtoy Journal: Endocrinology Date: 2016-01-26 Impact factor: 4.736
Authors: Jennifer Ariazi; Andrew Benowitz; Vern De Biasi; Monique L Den Boer; Stephanie Cherqui; Haifeng Cui; Nathalie Douillet; Eliseo A Eugenin; David Favre; Spencer Goodman; Karine Gousset; Dorit Hanein; David I Israel; Shunsuke Kimura; Robert B Kirkpatrick; Nastaran Kuhn; Claire Jeong; Emil Lou; Robbie Mailliard; Stephen Maio; George Okafo; Matthias Osswald; Jennifer Pasquier; Roel Polak; Gabriele Pradel; Bob de Rooij; Peter Schaeffer; Vytenis A Skeberdis; Ian F Smith; Ahmad Tanveer; Niels Volkmann; Zhenhua Wu; Chiara Zurzolo Journal: Front Mol Neurosci Date: 2017-10-17 Impact factor: 6.261
Authors: Kate E Keller; John M Bradley; Ying Ying Sun; Yong-Feng Yang; Ted S Acott Journal: Invest Ophthalmol Vis Sci Date: 2017-10-01 Impact factor: 4.799